In 2009 was created Life Sciences Fund Amsterdam, which is appeared as VC. The company was established in Europe in The Netherlands. The leading representative office of defined VC is situated in the Amsterdam.
Among the most popular fund investment industries, there are Communities, Medical Device. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight HiberCell, Neurent Medical.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Life Sciences Fund Amsterdam, startups are often financed by UvA Ventures Holding. The meaningful sponsors for the fund in investment in the same round are Western Development Commission, PPM Oost NV, Limburg Ventures. In the next rounds fund is usually obtained by PPM Oost NV, Holland Venture.
The fund was created by Harm de Vries, Tom Schwarz. The overall number of key employees were 2.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.
Related Funds
Funds with similar focus
Fund Name | Location |
Advancesoft | - |
Chicago Board Options Exchange | Chicago, Illinois, United States |
Cornerstone Ventures | Jeddah, Makkah, Saudi Arabia |
Danish Maritime Fund | - |
FbStart | California, Menlo Park, United States |
firedUP | Columbia, South Carolina, United States |
Goldcrest Capital | Dallas, Texas, United States |
Guoke Zhengdao Investment | Beijing, Beijing, China |
Intuit Prosperity Accelerator | - |
Lincolnshire Management | New York, New York, United States |
Medical Technology Venture Partners | California, San Francisco, United States |
Miller Johnson Steichen Kinnard Inc | Minneapolis, Minnesota, United States |
P Management 415 Inc. | - |
P3 Invest Zrt | Budapest, Hungary |
Presbyterian Health Foundation | Oklahoma, Oklahoma City, United States |
Prime Ventures | Amsterdam, Noord-Holland, The Netherlands |
Stonehammer Capital | - |
Two Shields Investments | England, United Kingdom, Wandsworth |
Vanguard Atlantic | New York, Saranac Lake, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
HiberCell | $60M | 07 Feb 2019 | New York, United States | ||
Neurent Medical | $11M | 28 May 2018 | Ireland, County Galway, Ireland | ||
Sigmascreening | 06 Oct 2010 | Amsterdam, North Holland, Netherlands |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
HiberCell | $60M | 07 Feb 2019 | New York, United States | ||
Neurent Medical | $11M | 28 May 2018 | Ireland, County Galway, Ireland | ||
Sigmascreening | 06 Oct 2010 | Amsterdam, North Holland, Netherlands |